Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability
BackgroundMicrosatellite instability (MSI) occurs in 3% of urothelial carcinomas as a result of germline or somatic loss of function mutation in mismatch repair (MMR) proteins.1 Although MSH4 is a member of the DNA MMR mutS family, the association of MSH4 mutation with MSI has not been described. We...
Main Authors: | Lei Wei, Sebastiano Battaglia, Yuanquan Yang, Rohit K Jain, Sean T Glenn, Prashant K Singh, Nicholas Hutson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/1/e000128.full |
Similar Items
-
Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
by: T. T. Andabekov, et al.
Published: (2019-07-01) -
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors
by: Pascale Palassin, et al.
Published: (2021-09-01) -
Genetic changes of MLH1 and MSH2 genes could explain constant findings on microsatellite instability in intracranial meningioma
by: Nives Pećina-Šlaus, et al.
Published: (2017-07-01) -
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
by: Qiao-Xuan Wang, et al.
Published: (2021-01-01) -
Microsatellite instability as prognostic marker in bladder tumors: a clinical significance
by: Mittal RD, et al.
Published: (2005-01-01)